| Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States | 1999/07/15 | English | 155 |
| Misunderstanding of prescription drug warning labels among patients with low literacy | 2006/06/01 | English | 153 |
| Impact of drug shortages on U.S. health systems | 2011/10/01 | English | 149 |
| Medication and nutrient administration considerations after bariatric surgery | 2006/10/01 | English | 145 |
| The consensus of the Pharmacy Practice Model Summit | 2011/06/15 | English | 143 |
| ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems | 2009/08/01 | English | 137 |
| Glaucoma and its treatment: A review | 2005/04/01 | English | 134 |
| Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism | 2007/01/01 | English | 134 |
| Medication administration through enteral feeding tubes | 2008/12/15 | English | 133 |
| Content versus label claims in ephedra-containing dietary supplements | 2000/05/15 | English | 130 |
| ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System | 2008/07/01 | English | 129 |
| Unsafe and potentially safe herbal therapies | 1999/01/01 | English | 129 |
| Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist | 2007/12/01 | English | 126 |
| Treatment of rheumatoid arthritis | 2006/12/15 | English | 125 |
| Tocilizumab: The first interleukin-6-receptor inhibitor | 2008/08/01 | English | 125 |
| Estimation of creatinine clearance in morbidly obese patients | 2009/04/01 | English | 125 |
| Effectiveness of a pharmacist-acquired medication history in promoting patient safety | 2002/11/15 | English | 125 |
| Lead toxicity and chelation therapy | 2007/01/01 | English | 124 |
| Impact of emerging technologies on medication errors and adverse drug events | 2003/07/15 | English | 124 |
| Hawthorn: Pharmacology and therapeutic uses | 2002/03/01 | English | 123 |
| Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate | 2002/06/01 | English | 122 |
| Using a closed-system protective device to reduce personnel exposure to antineoplastic agents | 2003/11/15 | English | 120 |
| ASHP Statement on the Pharmacist’s Role in Antimicrobial Stewardship and Infection Prevention and Control | 2010/04/01 | English | 120 |
| Gemcitabine: A cytidine analogue active against solid tumors | 1997/01/15 | English | 117 |
| Evidence of burnout in health-system pharmacists | 2018/12/01 | English | 116 |
| Depression in patients with HIV infection | 2000/02/15 | English | 115 |
| Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities | 1999/12/01 | English | 115 |
| Atypical antipsychotic agents: A critical review | 2000/02/01 | English | 115 |
| Use of colistin in the treatment of multiple-drug-resistant gram-negative infections | 2005/01/01 | English | 114 |
| Relationships between beliefs about medications and adherence | 2009/04/01 | English | 113 |